• SmD2 Acetylation Shapes PARP Response in HCC

  2026-08-29

  This 2024 Nature Communications study identifies acetylation-dependent control of the spliceosome protein SmD2 as a mechanistic link between alternative splicing, BRCA1/FANC expression, DNA damage repair, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its preclinical data support SmD2 and the HDAC2–p300 regulatory axis as potential determinants of response, while combination treatment with Romidepsin and Olaparib provides a rationale for further investigation in BRCA-proficient HCC.

• Plk1 Control of p31comet in Mitotic Checkpoint Exit

  2026-08-28

  The reference study identifies Polo-like kinase 1 (Plk1) as a direct regulator of p31comet, showing that phosphorylation at S102 suppresses p31comet–TRIP13-mediated disassembly of mitotic checkpoint complexes. This mechanism helps explain how active checkpoint signaling avoids a futile cycle of MCC assembly and disassembly and provides a useful framework for studying mitotic exit control.

• Genomic Instability and Therapy Heterogeneity in CRC

  2026-08-28

  Cho et al. combine patient-derived xenografts with whole-exome, transcriptomic, and DNA-methylation profiling to show that colorectal cancer metastasis is accompanied by coordinated genomic and regulatory change. Their results connect metastatic evolution with heterogeneous treatment responses, providing a mechanistic framework for studying resistance beyond a static primary-tumor biopsy.

• U 46619: From TP Signaling to Translational Strategy

  2026-08-27

  U 46619, also known as 11,9 epoxymethano-prostaglandin H2, is a selective TP receptor agonist that connects platelet activation with vascular and renal research. This thought-leadership guide shows how to use its mechanism, concentration-dependent readouts, and translational limitations to design stronger platelet, vascular tone, and hypertension studies.

• Self-Amplifying RNA Influenza Vaccines: Key Findings

  2026-08-27

  A 2026 study found that self-amplifying RNA produced stronger and more durable protection against influenza B than conventional nucleoside-modified mRNA in mice, while preserving dose-sparing performance against influenza A. The work highlights influenza-subtype and platform-specific determinants of RNA vaccine immunogenicity and provides a useful framework for comparing RNA vaccine architectures.

• AmpliFold Capture-and-Release for LFA Sensitivity

  2026-08-26

  The AmpliFold strategy addresses a central limitation of lateral flow assays: insufficient time for efficient analyte capture at a narrow test line. In a HER2 model, triggered release from a broad capture region followed by high-affinity rebinding produced up to 16-fold sensitivity enhancement and improved detection of large nanoparticles in buffer and serum.

• DeferoxamineB as a Control for Cell-Death Assays

  2026-08-26

  DeferoxamineB is a powerful iron-dependent perturbation tool for cancer research. This guide explains how to use Deferoxamine to distinguish ferroptosis, apoptosis, autophagy, and cuproptosis while improving metabolic assay design and interpretation.

• Alternariol AOH: From Exposure to Assay Design

  2026-08-25

  Alternariol (AOH) is more than a foodborne mycotoxin model: it is a layered perturbation tool for connecting metabolism, cell death, cytoskeletal remodeling, and hepatic stellate-cell activation. This guide translates recent LX-2 findings into practical assay decisions, controls, and interpretation strategies.

• Stattic Workflows for STAT3-Driven Cancer Research

  2026-08-25

  Stattic is a practical STAT3 inhibitor for connecting pathway mechanism with measurable cancer phenotypes, from nuclear translocation and apoptosis to radiosensitization. This workflow-focused guide shows how to apply it in HNSCC models and cautiously test the NF-κB–IL6–STAT3 biology highlighted in prostate cancer microbiome research.

• Potassium Iodide: Thyroid & Assay Workflows

  2026-08-24

  Potassium Iodide provides a defined iodide source for thyroid uptake, hormone-synthesis, and radioactive iodine competition studies. This protocol-driven guide also explains how to use KI as a carefully controlled compatibility variable alongside responsive liposome research—without confusing an analytical reagent with an immunotherapy payload.

• Stattic Workflows for STAT3 Pathway Research

  2026-08-24

  Stattic provides a practical way to test whether STAT3 signaling drives proliferation, apoptosis, migration, or radiation response in cancer and endothelial models. This workflow-focused guide combines HNSCC benchmarks with a recent lymphangiogenesis study to improve assay design, controls, and troubleshooting.

• Poly-PR, NEAT1, and HSP70 in TDP-43 Condensation

  2026-08-23

  The reference study identifies a NEAT1-dependent mechanism by which C9ORF72-associated poly-PR drives TDP-43 nuclear condensate formation and progressively reduces condensate fluidity. Its findings position HSP70 activity as a dynamic regulator of TDP-43 phase behavior, linking transient stress adaptation to oligomerization, mislocalization, and poly-PR toxicity.

• ECM–Mitochondria Crosstalk in Cell Stress

  2026-08-22

  The 2024 Cell study by Zhang and colleagues identifies extracellular-matrix remodeling as an upstream regulator of mitochondrial homeostasis. Its central model links hyaluronan degradation through TMEM2 to TGF-β signaling, mitochondrial fission, mitochondrial stress responses, and enhanced pathogen defense, providing a framework for testing how extracellular damage is converted into intracellular adaptation.

• Phosphatase Inhibitor Cocktail 3 for Phosphoproteins

  2026-08-22

  Preserve phosphorylation during neuronal OGD, tissue extraction, Western blotting, co-immunoprecipitation, and kinase workflows with a concentrated inhibitor blend. This guide connects practical sample handling to ferroptosis-focused research while separating product-supported parameters from assay-specific optimization.

• Stattic: Practical STAT3 Inhibitor Workflows

  2026-08-21

  Stattic provides a rapid pharmacological route to test STAT3-dependent proliferation, apoptosis, HIF-1 regulation, and radiosensitivity. This guide connects validated HNSCC applications with a carefully bounded extension into keratinocyte and psoriasis research, emphasizing controls, assay compatibility, and troubleshooting.

8110 records 1/541 page Next 12345 下5页 Last page